| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Absence of an association between rubella vaccination and arthritis in underimmune postpartum women
|
Slater, Paul E.
|
|
1995
|
13 |
16 |
p. 1529-1532
4 p.
|
article
|
| 2 |
A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model
|
Russell, P.
|
|
1995
|
13 |
16 |
p. 1551-1556
6 p.
|
article
|
| 3 |
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity
|
Kotloff, Karen L.
|
|
1995
|
13 |
16 |
p. 1488-1494
7 p.
|
article
|
| 4 |
A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine
|
Race, Esther
|
|
1995
|
13 |
16 |
p. 1567-1575
9 p.
|
article
|
| 5 |
Antiallergic vaccine containing polypeptide fragment of IgE heavy chain; recombinant vaccine production IgE Fc-epsilon monomer fragment expression in Escherichia coli using vector plasmid pE2-4
|
|
|
1995
|
13 |
16 |
p. 1626-
1 p.
|
article
|
| 6 |
Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type B conjugate vaccines given for primary immunisation by separate or mixed injection
|
Begg, Norman T.
|
|
1995
|
13 |
16 |
p. 1547-1550
4 p.
|
article
|
| 7 |
Calendar
|
|
|
1995
|
13 |
16 |
p. 1627-
1 p.
|
article
|
| 8 |
Cholera vaccine containing stable nontoxigenic Vibrio cholerae mutant; recombinant vaccine strain improvement
|
|
|
1995
|
13 |
16 |
p. 1626-
1 p.
|
article
|
| 9 |
Cross-reaction but no avidity change of the serum antibody response after influenza vaccination
|
Brokstad, Karl Albert
|
|
1995
|
13 |
16 |
p. 1522-1528
7 p.
|
article
|
| 10 |
Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) via the experience of the Children's Hospital La Fe, Valencia, Spain
|
Asensi, F.
|
|
1995
|
13 |
16 |
p. 1563-1566
4 p.
|
article
|
| 11 |
Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59
|
Ott, Gary
|
|
1995
|
13 |
16 |
p. 1557-1562
6 p.
|
article
|
| 12 |
Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain
|
Gómez-Duarte, Oscar G.
|
|
1995
|
13 |
16 |
p. 1596-1602
7 p.
|
article
|
| 13 |
Finer mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system
|
Seif, Said A.
|
|
1995
|
13 |
16 |
p. 1515-1521
7 p.
|
article
|
| 14 |
Human parvovirus gene coding for a polypeptide; VP-1 and VP-2 and nonstructural protein expression in e.g. Escherichia coli for use in disease diagnosis or recombinant vaccine construction
|
|
|
1995
|
13 |
16 |
p. 1626-
1 p.
|
article
|
| 15 |
Immune response and protection against influenza A infection in mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine
|
Tamizifar, Hassan
|
|
1995
|
13 |
16 |
p. 1539-1546
8 p.
|
article
|
| 16 |
Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection
|
Lee, Hoan-Jong
|
|
1995
|
13 |
16 |
p. 1533-1538
6 p.
|
article
|
| 17 |
Induction of systemic immune responses to measles virus synthetic peptides administered intranasally
|
Hathaway, L.J.
|
|
1995
|
13 |
16 |
p. 1495-1500
6 p.
|
article
|
| 18 |
Jonas Salk
|
Spier, R.E.
|
|
1995
|
13 |
16 |
p. 1487-
1 p.
|
article
|
| 19 |
Measles, mumps, and rubella antibodies in children 5–6 years after immunization: effect of vaccine type and age at vaccination
|
Boulianne, Nicole
|
|
1995
|
13 |
16 |
p. 1611-1616
6 p.
|
article
|
| 20 |
New Advances in Vaccine Technologies and Applications
|
Gupta, Rajesk K.
|
|
1995
|
13 |
16 |
p. 1623-1625
3 p.
|
article
|
| 21 |
New enzymatic RNA molecules; ribozyme specific for hepatitis C virus, for use in intracellular immunization, therapy or defective virus particle attenuated recombinant vaccine production
|
|
|
1995
|
13 |
16 |
p. 1626-
1 p.
|
article
|
| 22 |
New nucleic acid encoding highly cross-reactive allergen; grass, birch, ragweed or Parietaris sp. pollen allergen gene cloning and expression using a plasmid pNH1 vector, for use as an antiallergic recombinant vaccine
|
|
|
1995
|
13 |
16 |
p. 1626-
1 p.
|
article
|
| 23 |
Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination. A nine-year follow-up
|
Davidkin, Irja
|
|
1995
|
13 |
16 |
p. 1617-1622
6 p.
|
article
|
| 24 |
Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture
|
Robertson, James S.
|
|
1995
|
13 |
16 |
p. 1583-1588
6 p.
|
article
|
| 25 |
Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus
|
Scott Gallichan, W.
|
|
1995
|
13 |
16 |
p. 1589-1595
7 p.
|
article
|
| 26 |
Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines
|
Twomey, Traci
|
|
1995
|
13 |
16 |
p. 1603-1610
8 p.
|
article
|
| 27 |
Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles
|
Vordermeier, H.M.
|
|
1995
|
13 |
16 |
p. 1576-1582
7 p.
|
article
|
| 28 |
The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis
|
Idänpään-Heikkilä, Ilona
|
|
1995
|
13 |
16 |
p. 1501-1508
8 p.
|
article
|
| 29 |
Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation
|
Jansen, Kathrin U.
|
|
1995
|
13 |
16 |
p. 1509-1514
6 p.
|
article
|
Journal description